Ken Griffin’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
Other funds holding DYN
Ken Griffin's DYN Position: Q3 2026 in Review
Ken Griffin increased its Dyne Therapeutics (DYN) stake by 71% in Q3 2026, buying an estimated $18.6M and bringing the position to 1,954,745 shares worth $31.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2033.
Ken Griffin first reported a position in DYN in Q3 2020 and has held it in 25 quarters since. The position peaked at $152M in Q2 2024. 270 funds tracked by Wall St. Rank hold DYN as of Q3 2026.
- Ken Griffin held 1,954,745 shares of Dyne Therapeutics worth $31.5M as of Q3 2026.
- Ken Griffin bought 810,787 Dyne Therapeutics shares in Q3 2026, an estimated $18.6M.
- Dyne Therapeutics made up ﹤0.01% of Ken Griffin's portfolio in Q3 2026, its #2033 holding.
- Ken Griffin first reported a position in Dyne Therapeutics in Q3 2020 and has held it in 25 quarters since.
- Ken Griffin's Dyne Therapeutics position peaked at $152M in Q2 2024.
- 270 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q3 2026.
Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.